软组织尤宁肉瘤细胞药物耐药性重审:一个系统生物学方法
Seyedehsadaf Asfa1,2, Halil Ibrahim Toy1,2, Reza Arshinchi Bonab1,2
1Izmir Biomedicine and Genome Center (IBG), 35340 Izmir, Turkey.
概括
这项研究确定了关键基因和非编码RNAs,这些基因和非编码RNAs在尤文肉瘤中驱动化学抵抗. 这些发现可能会改善药物反应预测,并个性化瘤治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 尤文肉瘤是一种罕见的骨和软组织癌症.
- 化疗是主要治疗方法,但耐药性限制了疗效.
- 了解化学抵抗机制对于改善治疗结果至关重要.
研究的目的:
- 为了确定尤文肉瘤中化学抵抗的分子机制.
- 发现克服药物耐药性的新型治疗点.
- 探索非编码RNA和自主神经系统在化学抵抗中的作用.
主要方法:
- 从化学抵抗性和化学反应性尤金肉瘤细胞的转录数据的差异性基因表达分析.
- 功能性丰富分析和蛋白质-蛋白质相互作用网络以确定枢纽基因.
- 对非编码RNA调节器的研究,这些调节器针对化学抵抗基因.
主要成果:
- 确定了对尤文肉瘤化学抵抗至关重要的枢纽基因.
- 发现了潜在调节化学抵抗相关基因的非编码RNA.
- 发现化学抵抗基因与自主神经系统之间的关联.
结论:
- 这项研究阐明了Ewing瘤化学抵抗中的关键分子参与者.
- 研究结果表明,针对已识别的基因和RNA的新型治疗策略有潜力.
- 自主神经系统在药物反应中的作用需要进一步研究临床应用.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


